Stop 483s before they start — document control templates built for 21 CFR 820.40 and ISO 13485 §4.2
Six documents for a complete, inspection-ready document control system.
Instant download. For QA managers at FDA-registered medical device manufacturers.
FDA 21 CFR 820.40 and ISO 13485 §4.2 require documented procedures for controlling every document in your QMS — creation, review, approval, distribution, revision, and obsolescence. The most common gaps: no approval evidence before use, obsolete documents still in circulation, and personnel using undocumented revisions.
This toolkit gives you the procedure, the forms, the register, the training checklist, the retention schedule, and the FDA audit prep guide — everything needed to build a document control system that holds up under inspection.
From document creation through retention, destruction, and FDA audit readiness.
Complete SOP covering creation, review, approval, distribution, revision, and obsolescence of controlled documents. FDA 21 CFR 820.40 compliant. Includes document numbering scheme, revision control matrix, and obsolescence workflow.
Structured form to track change requests, impact assessments, required approvals, and implementation verification. Captures reason for change, affected documents, cross-functional review, and post-change effectiveness confirmation.
Living index of all controlled documents with current revision status, document owner, next review date, and distribution list. Pre-formatted for FDA inspection-readiness and ISO 13485 §4.2 compliance.
Ensures all affected personnel are trained and acknowledged before new or revised documents go live. Captures trainer, trainee, training method, competency verification, and completion date for each document change.
FDA and ISO retention requirements mapped by document type — DHFs, DMRs, complaint files, CAPAs, training records, and more. Includes destruction authorization workflow and certificate of destruction template.
What investigators actually look for in document control systems — 483 citation patterns, common gaps, questions inspectors ask. Includes a pre-inspection readiness checklist and guidance on presenting your document control program.
Every template maps directly to regulatory requirements. No generic document management theory — these are FDA-ready documents designed for the inspection environment.
Skip the 40-80 hours of building from scratch. The procedure, forms, and registers are pre-structured. Fill in your company name and document numbering scheme and you're operational.
Document control is the backbone of your QMS. These templates link to CAPA, training, supplier controls, and design controls — consistent structure across every system.
21 CFR 820.40 (now incorporated into the FDA Quality Management System Regulation, QMSR) requires FDA-registered medical device manufacturers to establish and maintain procedures for controlling documents. This includes approvals before use, change management, identification of current revision status, availability at point of use, removal of obsolete documents, and retention of changed documents. Failure to comply is one of the most commonly cited 483 observation categories.
Documents are the instructions, procedures, and templates that tell people what to do — SOPs, work instructions, forms, specifications. Records are the completed evidence that something was done — filled-in forms, completed checklists, test results. FDA 820.40 covers document control; 820.180 covers records. Both require controlled access, revision management, and defined retention. This toolkit focuses on the document side, with the retention schedule covering both.
FDA 21 CFR 820.180 requires most QMS records be retained for the expected useful life of the device, with a minimum of 2 years from device release. The DHF must be retained for the life of the device. ISO 13485 §4.2.5 specifies at least the lifetime of the device defined by the organization, or as specified by applicable regulations. The Retention & Destruction Schedule in this toolkit maps specific retention periods by document type with regulatory citations.
Investigators commonly check: are documents approved before use and re-approved when changed? Are obsolete documents removed or marked to prevent unintended use? Are current revision levels identifiable in the field? Is there evidence personnel are trained on document changes before implementation? Are distribution controls in place for external documents (customer specs, standards)? The FDA Audit Prep Guide covers all of these with the actual 483 citation language.
No. This is a practitioner reference toolkit. Consult your regulatory counsel and qualified regulatory affairs professionals for formal compliance opinions.
FDA guidance, warning letters, and compliance intel — delivered daily by RegWatch Daily.
Six documents. Instant download. 21 CFR 820.40 + ISO 13485 §4.2.
Also: CAPA Toolkit $247 · Supplier Controls $247 · Full Suite $449